Algeos expands pressure-care portfolio through new Caversham® partnership
Algeos has expanded its pressure-care portfolio through a new distribution partnership with Caversham®, making four specialist Class I medical devices available to healthcare professionals and care providers across the UK.
There are currently an estimated 4.8 million people in the UK living with diabetes. Of that cohort, approximately 10% will develop a diabetic foot ulcer. To help you understand and prevent these issues, we've compiled a list of frequently asked questions (FAQs) about diabetic foot ulcers.
